Boards & Committees - Education


Education Committee Meeting (La Jolla AB)
Thursday, April 10, 2014
12:30 PM - 1:45 PM

Education Committee Report to the Board (Gaslamp

Friday, April 11,
7:00 PM

Both events will take place at the
Manchester Grand Hyatt Hotel, San Diego, CA, USA


The Board of Directors in Montreal unanimously adopted a strategy policy for ISHLT Educational Affairs.

For the ISHLT Academy a curriculum process has been introduced. Designated extra-curricular events and other learning modules will provide complimentary options (separate from the ISHLT Academy).

A conceptual framework and a clear process to align all of the existing and any planned educational activities has been devised. Please take a moment to familiarize yourself with the strategic plan and terminology.

White Paper for Education at ISHLT: A Pathway for a Coherent Strategy for Educational Affairs (PDF)


Chris Wigfield MD MD FRCS(C/Th)
Educational Affairs Director, ISHLT


  • The overall educational strategy for the Society shall be implemented by the Director of Educational Affairs.  The Director of Educational Affairs shall be selected by the Board of Directors following an application and interview process. The term is for 5 years, renewable for one additional year at a time for a maximum term of 10 years.  The Director shall receive a stipend of $20,000 per year.  The Director of Educational Affairs shall serve as an ex-officio member of the Board of Directors and as the Chair of the Education Committee.
  • The Education Committee shall be chaired by the Director of Educational Affairs.  The leader of each Scientific Council Education Workforce shall serve on the Committee.
  • The Annual Meeting Scientific Program Chair, the Annual Meeting Scientific Program Chair-Elect, and the Chair(s) of the current and incoming year’s educational activities shall serve on the Committee.
  • The DIrector may appoint up to three at large committee members to serve one-year, renewable terms for the purpose of ensuring broad representation on the Committee.

  1. Ensure that the educational activities of the Society meet ACCME requirements as well as those of other medical education program accrediting bodies as directed by the Board of Directors.
  2. Identify the ongoing practice gaps and educational needs of the Society's members.
  3. Develop strategies and plans for the delivery of educational programs and services that meet the identified educational needs.
  4. Ensure that planned educational programs and services have content and learning objectives that meet the identified educational needs.
  5. Evaluate the quality of ISHLT's educational programs and make recommendations for improvements and changes to future content and format.
  6. Develop criteria to which all ISHLT educational programs must adhere, to include the following: content and speaker selection standards; endorsement of educational programs by other organizations; development of educational programs jointly with other organizations.
  7. Review educational program proposals developed by the Scientific Councils.
  8. Refer discipline-specific proposals for educational programs to the appropriate Scientific Council Education Workforce for development into formal proposals.
  9. Act as liaison between the Scientific Council Education Workforces, the proposed educational program chair(s), and the Board to facilitate the development of well structured education program proposals to the board, with appropriate budget proposals.
  10. Evaluate requests from other organizations for ISHLT to co-sponsor or endorse educational programs and make recommendations to the Board of Directors for action.
Christopher H. Wigfield, MD FRCS(C/Th)
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA

Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at the University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.

Jason D. Christie, MD, MS
University of Pennsylvania
Philadelphia, Pennsylvania, USA

Jason Christie, MD, MS, is the Section Chief of Medical Critical Care at the University of Pennsylvania Perelman School of Medicine. He is currently Associate Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania. He is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics, and the Director of Clinical Research in the Pulmonary Division. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury (ALI) in the transplant and non-transplant human populations..

Andreas Zuckermann, MD,
Medical University of Vienna

Bio coming soon...

Lori J. West, MD, DPhil
University of Alberta
Edmonton, Alberta, CANADA

Dr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.
Marilia Cascalho, MD, PhD
University of Michigan Medical School
Ann Arbor, MI, USA

Bio coming soon...
David Baran, MD
Newark Beth Israel Medical Center
Newark, New Jersey, USA

David Baran, MD, is the Director of Heart Failure and Transplant Research at Newark Beth Israel Medical Center in Newark, New Jersey.  Dr. Baran graduated from the University of South Florida College of Medicine and completed his internal medicine residency at Columbia-Presbyterian Medical Center in New York City. His specialty training includes a congestive heart failure clinical/research fellowship both at Columbia Presbyterian Medical Center, as well as a clinical cardiology fellowhip at Mount Sinai Medical Center, New York City.  Dr. Baran is board certified in internal medicine and cardiology and is certified by the United Network for Organ Sharing (UNOS) as a transplant cardiologist. He is a skilled invasive cardiologist with special competency in endomyocardial biopsy and diagnostic angiography.  He has special interest in heart failure treatment trials and immunosuppression research.
Me-Linh Luong, MD
University of Montréal
St-Luc Hospital, Centre Hospitalier de l'Universite de Montréal (CHUM)
Montreal, CANADA
514-890-8000 ext. 34760

Me-Linh Luong, MD is an assistant professor of Medicine at the University oF Montreal, Montreal, Canada. Dr. Luong earned her MD at the University of Sherbrooke and subsequently completed her residency in Internal Medicine at University of Montreal. She went on to complete an Infectious Diseases and Medical Microbiology fellowship at McGill University followed by a postgraduate training in Transplant Infectious Diseases at the University of Toronto, Canada. Her main research interests include the epidemiology and outcome of fungal infection in lung transplant recipients, novel diagnostics methods for fungal infections and antifungal treatment.
Jonathan N. Johnson, MD
Mayo Clinic
Rochester, Minnesota, USA

Jonathan Johnson, MD is an associate professor of Pediatrics at the Mayo Clinic in Rochester, Minnesota, where he is the medical director of the Pediatric Heart Transplant Program.  Dr. Johnson received his medical degree from Wayne State University in 2005.  He completed training in Pediatric and Adolescent Medicine at the Mayo Clinic in 2008, and subsequently went on to complete subspecialty training in Pediatric Cardiology at Mayo in 2011.  Dr. Johnson’s research interests focus on improving clinical outcomes of pediatric heart failure and transplant patients, the use of mTOR inhibitors in the pediatric population, and on novel methods to non-invasively detect allograft rejection.  He also serves as co-director of CME programs for the Department of Pediatrics at the Mayo Clinic, and has a particular interest in symposium and meeting development.
Salpy V. Pamboukian, MD, MSPH
University of Alabama at Birmingham
Birmingham, Alabama, USA

Dr. Pamboukian completed her MD degree at the University of Toronto, Canada, where she also completed an internal medicine residency. She received a cardiology fellowship at the University of British Columbia, Vancouver, followed by a cardiac transplantation and heart failure fellowship at Rush-Presbyterian — St. Luke’s Medical Center in Chicago, Illinois. Presently, she is Medical Director of the Mechanical Circulatory Support Device Program and co-section head of the Section of Advanced Heart Failure, Cardiac Transplant, Mechanical Circulatory Support and Pulmonary Vascular Disease at the University of Alabama at Bimingham.
Michael Petty, PhD, RN, CCNS, ACNS-BC
University of Minnesota Medical Center-Fairview
Minneapolis, Minnesota, USA

Dr. Michael Petty is a Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Fairview. He received his bachelors degree in nursing from the University of the State of New York, his Masters in Nursing from the University of Minnesota-Twin Cities in 1996 and earned his PhD at the University of Minnesota School of Nursing in 2011. He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years.  Much of his practice during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions including LVADs. His research interests are with LVAD therapy, with a focus on Caregiver Burden and Quality of Life for those caring for LVAD patients.
Debra A. Dodd, MD
Vanderbilt  Children's Hospital
Nashville, Tennessee, USA

Dr. Debra Dodd graduated from medical school at The Johns Hopkins University.  Her pediatric and pediatric cardiology training was at Vanderbilt Children’s Hospital.  Following her training, she remained at Vanderbilt Children’s Hospital where she helped establish a Pediatric Heart Transplant Program at VCH in 1989 and has been Medical Director of the Pediatric Heart Transplant Program since 1993.
Haifa Lyster, MSc
Royal Brompton & Harefield NHS Trust
Harefield, Middlesex, UNITED KINGDOM

Haifa Lyster is a Consultant Pharmacist in Transplantation & Ventricular Assist Devices at Royal Brompton & Harefield NHS Foundation Trust. She graduated from the School of Pharmacy, University of Bath in 1992 and continued her studies obtaining a Masters degree at London School of Pharmacy and is a qualified independent non-medical prescriber. Haifa has worked in thoracic transplantation & VADs based at Harefield hospital since 1998 with a leading role in managing VAD and heart and lung transplant patients in all aspects of their pharmaceutical care, particularly in anti-infective and immunosuppression regimens. Haifa has authored a number of chapters on immunosuppression and heart failure, as well as review and original research articles in peer-reviewed journals including Transplantation and the Journal of Heart and Lung Transplantation and has an ongoing research interest in therapeutic drug monitoring of azoles and their efficacy in management of fungal infections. Haifa is responsible for induction of all new medical staff into prescribing practice in the department of transplantation and  lectures on national and international conferences in her field.
Dana P. McGlothlin, MD
Kaiser San Francisco
San Francisco, California, USA

Bio coming soon...
Kevin M. Chan, MD
Univ of Michigan Health System
Ann Arbor, Michigan, USA

Kevin Chan, MD, is Medical Director of Lung Transplantation and Fellowship Program Director in the Division of Pulmonary and Critical Care Medicine at the University of Michigan in Ann Arbor, MI, USA. Dr. Chan received his medical degree from Wayne State University, completed his internal medicine residency at Rush Presbyterian St. Luke’s Medical Center in Chicago, and fellowship in Pulmonary and Critical Care Medicine at the University Of California Los Angeles Center for the Health Sciences.
Esme Dijke, PhD
University of Alberta
Dept of Ped, Lab of Dr. Lori J. West
Edmonton, Alberta, CANADA

Esmé Dijke works as a Post-doctoral Fellow at the University of Alberta in Edmonton under the supervision of Dr. Lori West. She graduated cum laude from the Rotterdam University in Rotterdam (Netherlands) with a Bachelor of Applied Sciences degree in Biotechnology. She received her PhD in the laboratory of Dr. Carla Baan and Dr. Willem Weimar at the Erasmus University in Rotterdam, where her doctoral studies focused on the role of regulatory T cells in adult heart transplant recipients. Her research interests are the role of regulatory T cells and B-cell memory in infants and its possible relation to development of tolerance to graft antigens.

Andrew J. Fisher, FRCP, PhD
Freeman Hospital
Newcastle Upon Tyne, UK

Andrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.

Peter M Hopkins, FRACP
The Prince Charles Hospital
Brisbane, Queensland, AUSTRALIA

Bio coming soon...

Jon A. Kobashigawa, MD
Cedars Sinai Heart Institute
Los Angeles, CA, USA

Bio coming soon...

Jeffrey J. Teuteberg, MD
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA

Jeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.

Andreas Zuckermann, MD
Medical University of Vienna

Bio coming soon...
Text SizeIncrease Font SizeDecrease Font Size